drugset / Trial / NCT03970798
A Drug Interaction Study of KW-6356 With Midazolam, Caffeine, or Rosuvastatin
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the influence of repeated oral doses of KW-6356 on the pharmacokinetics of index substrates for CYP3A4/5, CYP1A2 and BCRP.
Timeline
- Start
- 2019-05-22
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caffeine | Small molecule | — | — |
| Subject | Midazolam | Small molecule | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |
| Subject | SIPAGLADENANT | Small molecule | — | — |